GSK2831781 - Open Label phase

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03893565 (ClinicalTrials.gov)	May 6, 2019	26/3/2019	Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis	A Multicentre Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety, Tol ...	Colitis, Ulcerative	Drug: GSK2831781 - Double Blind Phase;Drug: Placebo;Drug: GSK2831781 - Open Label phase	GlaxoSmithKline	NULL	Terminated	18 Years	N/A	All	104	Phase 2	United States;Bulgaria;Czechia;Estonia;France;India;Japan;Netherlands;Poland;Russian Federation;Serb ...

First Previous1Next Last